Article Details

Dr. Ferrajoli on the Benefits and Limitations of Frontline Fixed-Duration Therapy in CLL

Retrieved on: 2023-09-15 18:03:21

Tags for this article:

Click the tags to see associated articles and topics

Dr. Ferrajoli on the Benefits and Limitations of Frontline Fixed-Duration Therapy in CLL. View article details on HISWAI: https://www.onclive.com/view/dr-ferrajoli-on-the-benefits-and-limitations-of-frontline-fixed-duration-therapy-in-cll

Excerpt

Alessandra Ferrajoli, MD, discusses the benefits and limitations of utilizing fixed-duration therapy with monoclonal antibodies in the frontline ...

Article found on: www.onclive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up